A combination of anti‐PD‐L1 mAb plus Lm‐LLO‐E6 vaccine efficiently suppresses tumor growth and metastasis in HPV‐infected cancers

PD‐1/PD‐L1 immunotherapy is viewed as having clinical benefits in advanced cancers but is effective in only a few patients, suggesting that an efficient combination approach is needed to improve efficacy. Immunohistochemistry analysis indicated that PD‐L1 expression was correlated with the E6 expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Po‐Lin, Cheng, Ya‐Min, Wu, De‐Wei, Huang, Yu‐Ju, Lin, Hun‐Chi, Chen, Chih‐Yi, Lee, Huei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603833/
https://www.ncbi.nlm.nih.gov/pubmed/28795532
http://dx.doi.org/10.1002/cam4.1143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603833/
https://www.ncbi.nlm.nih.gov/pubmed/28795532
http://dx.doi.org/10.1002/cam4.1143

Ejemplares similares